IBRX Archived Articles
ImmunityBio, Inc. (IBRX): Pioneering the Next Generation of Cancer Immunotherapies
Published on November 30, 2024
ImmunityBio, Inc. (IBRX): Poised for Growth with Approved Product and Robust Pipeline
Published on September 24, 2024